News

Cranial electrotherapy stimulation – otherwise known as CES – is a treatment cleared by the FDA for addressing insomnia in patients. Completely non-invasive and safe, it works to encourage the brain to react appropriately to the need for rest. The severity of insomnia can vary depending on how early or late it occurs in a typical sleep cycle. Today, let’s explore in further detail...

tDCS has long been appreciated as a non-invasive way to adjust emotional reactivity and effectively steer the mind in decision-making. A key benefit of the technology is its ability to improve mental focus in individuals, and evoke a more motivating learning experience. Today, let’s touch on the essentials of tDCS devices and list our favorites for improving learning capabilities. An Overview of What tDCS...

Update: December 20, 2019 The Food and Drug Administration (FDA) has reclassified CES devices intended for the treatment of anxiety and/or insomnia from Class III to Class II medical devices. CES devices intended for the treatment of depression will remain Class III and need to file a premarket approval application (PMA) to retain clearance for depression. This article has been updated to reflect those...

Ever heard of Transcranial Direct Current Stimulation? At Caputron, it’s one of our specialties. Otherwise known as tDCS, this innovative non-invasive neurostimulation technology is ideal for modulating brain activity associated with various behavioral issues. It harnesses the brain’s neural circuitry to help alleviate emotional and psychological distress. This is achieved by delivering completely safe, subtle electrical impulses via electrodes attached to the subject’s head....

The featured image appeared originally in a publication of Business Insider. We at Caputron are a world-leading distributor of clinical and research-based neurostimulation technology. One of the most widely used forms of this technology is tDCS. However, what if you’ve never heard of this means of neurostimulation before and want to understand it better? We’re here to help! Let’s explore the basics of the...

Update: December 20, 2019 The Food and Drug Administration (FDA) has reclassified CES devices intended for the treatment of anxiety and/or insomnia from Class III to Class II medical devices. CES devices intended for the treatment of depression will remain Class III and need to file a premarket approval application (PMA) to retain clearance for depression. This article has been updated to reflect those...

Music designed with your brain in mind! Brain FM works with teams of scientists and composers to engineer music specifically designed to help you achieve and sustain deep focus. Try now for FREE! Brain FM uses an AI music engine to create music geared to help you improve focus, relaxation or sleep. Combine musical modulation with neuromodulation technqiues such as tDCS or CES to...

Choosing the best tDCS device can be tricky. With so many choices now available, it is important to know what features to look for. The 5 most important features you should consider when choosing a tDCS device are: Build Quality - The highest quality consumer devices are professional grade. Accurate Current Delivery - Does the device have enough power (minimum 20 volts max output)...

At Caputron, our goal is to not only provide the best tDCS devices but also provide the best customer support possible. We are continuously working on creating new content and putting together instructional videos highlighting the features available in each tDCS device and their respective starter kits. In these videos we will show you, what is included in each starter kit as well as...

“The Potential and Limitations of Transcranial Direct Current Stimulation” talk by Marom Bikson at SOBP 2018 conference  Reviewed by the Caputron team